SCP
CDLX icon

Sender Company & Partners’s Cardlytics CDLX Stock Holding History

Sender Company & Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,644
Closed -$210K – 164
2025
Q3 		$210K Buy
+8,644
New +$144K 0.02% 398

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sender Company & Partners's CDLX Position: Q4 2025 in Review

Sender Company & Partners sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 8,644 shares — an estimated $210K sold.

Sender Company & Partners first reported a position in CDLX in Q3 2025 and held it in 1 quarter. The position peaked at $210K in Q3 2025. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

  • Sender Company & Partners reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
  • Sender Company & Partners sold 8,644 Cardlytics shares in Q4 2025, an estimated $210K.
  • Sender Company & Partners first reported a position in Cardlytics in Q3 2025 and held it in 1 quarter.
  • Sender Company & Partners's Cardlytics position peaked at $210K in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on Sender Company & Partners's 13F filing for Q4 2025, filed 17 Feb 2026.